TY  - GEN
AU  - Guarneri,Valentina
AU  - Miles,David
AU  - Robert,Nicholas
AU  - Diéras,Véronique
AU  - Glaspy,John
AU  - Smith,Ian
AU  - Thomssen,Christoph
AU  - Biganzoli,Laura
AU  - Taran,Tanya
AU  - Conte,PierFranco
TI  - Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer
SN  - 1573-7217
PY  - 2010///1025
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Breast Neoplasms
KW  - complications
KW  - Diphosphonates
KW  - Docetaxel
KW  - Double-Blind Method
KW  - Drug Synergism
KW  - Female
KW  - Genes, erbB-2
KW  - Humans
KW  - Incidence
KW  - Jaw Diseases
KW  - chemically induced
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - statistics & numerical data
KW  - Neoplasm Metastasis
KW  - Oral Hygiene
KW  - Osteonecrosis
KW  - Paclitaxel
KW  - Prospective Studies
KW  - Randomized Controlled Trials as Topic
KW  - Taxoids
KW  - Vinblastine
KW  - Vinorelbine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10549-010-0866-3
ER  -